Leavitt Medical, Inc. – Trademark Portfolio
Entity Type: 03
Leavitt Medical, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 7 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include LUMEA. The owner is based in Lehi, UT.
2889 W. Ashton Boulevard, Unit 300
Lehi, UT 84043
Showing of trademarks Trademarks
Trademark Classifications
Leavitt Medical, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Leavitt Medical, Inc. have?
Leavitt Medical, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 cancelled.
What trademark classes does Leavitt Medical, Inc. file in?
Leavitt Medical, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Leavitt Medical, Inc.'s most well-known trademarks?
Leavitt Medical, Inc.'s registered trademark portfolio includes well-known marks such as LUMEA. These are among 2 currently registered trademarks in the portfolio.
What is Leavitt Medical, Inc.'s trademark registration success rate?
Leavitt Medical, Inc. has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.